BibTex format
@article{Davis:2021:10.12688/wellcomeopenres.16783.1,
author = {Davis, AG and Wasserman, S and Maxebengula, M and Stek, C and Bremer, M and Daroowala, R and Aziz, S and Goliath, R and Stegmann, S and Koekemoer, S and Jackson, A and Lai, Sai L and Kadernani, Y and Sihoyiya, T and Liang, CJ and Dodd, L and Denti, P and Crede, T and Naude, J and Szymanski, P and Vallie, Y and Banderker, I and Moosa, S and Raubenheimer, P and Lai, RPJ and Joska, J and Nightingale, S and Dreyer, A and Wahl, G and Offiah, C and Vorster, I and Candy, S and Robertson, F and Meintjes, E and Maartens, G and Black, J and Meintjes, G and Wilkinson, RJ},
doi = {10.12688/wellcomeopenres.16783.1},
journal = {Wellcome Open Research},
title = {Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]},
url = {http://dx.doi.org/10.12688/wellcomeopenres.16783.1},
volume = {6},
year = {2021}
}